Leptin increased and urinary cortisol secretion decreased during dronabinol therapy.
The levels of bioactive IGF-I were negatively influenced by the amount of energy expenditure.
The circulating IGF-system was unaffected by the dronabinol induced weight gain.
Circulating adiponectin also remained unaffected by dronabinol treatment.